D
Donghoon Choi
Researcher at Yonsei University
Publications - 1107
Citations - 20602
Donghoon Choi is an academic researcher from Yonsei University. The author has contributed to research in topics: Stent & Myocardial infarction. The author has an hindex of 56, co-authored 1015 publications receiving 17538 citations. Previous affiliations of Donghoon Choi include Korea Institute of Science and Technology & Cardiovascular Institute Hospital.
Papers
More filters
Journal ArticleDOI
A New Strategy for Discontinuation of Dual Antiplatelet Therapy The RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)
Byeong Keuk Kim,Myeong Ki Hong,Dong Ho Shin,Chung Mo Nam,Jung Sun Kim,Young Guk Ko,Donghoon Choi,Tae-Soo Kang,Byoung-Eun Park,Woong-Chol Kang,Seung Hwan Lee,Junghan Yoon,Bum-Kee Hong,Hyuck Moon Kwon,Yangsoo Jang,Reset Investigators +15 more
TL;DR: E-ZES+3-month DAPT was noninferior to the standard therapy with respect to the occurrence of the primary endpoint, and the recurrence of any death, myocardial infarction, or stent thrombosis at 1 year was recorded.
Journal ArticleDOI
A Paclitaxel-Eluting Stent for the Prevention of Coronary Restenosis
Seung-Jung Park,Won Heum Shim,David Sai Wah Ho,Albert E. Raizner,Seong Wook Park,Myeong Ki Hong,Cheol Whan Lee,Donghoon Choi,Yangsoo Jang,Ricky Lam,Neil J. Weissman,Gary S. Mintz +11 more
TL;DR: Paclitaxel-eluting stents used with conventional antiplatelet therapy effectively inhibit restenosis and neointimal hyperplasia, with a safety profile similar to that of standard stents.
Journal ArticleDOI
Effect of intravascular ultrasound-guided vs angiography- guided everolimus-eluting stent implantation: The IVUS-XPL randomized clinical trial
Sung Jin Hong,Sung Jin Hong,Byeong Keuk Kim,Dong Ho Shin,Chung Mo Nam,Jung Sun Kim,Young Guk Ko,Donghoon Choi,Tae-Soo Kang,Woong-Chol Kang,Ae-Young Her,Yong Hoon Kim,Seung Ho Hur,Bum-Kee Hong,Hyuck Moon Kwon,Yangsoo Jang,Myeong Ki Hong +16 more
TL;DR: The use of IVUS-guided everolimus-eluting stent implantation, compared with angiography-guided stent implants, resulted in a significantly lower rate of the composite of major adverse cardiac events at 1 year, primarily due to lower risk of target lesion revascularization.
Journal ArticleDOI
2,5-Bis(2-octyldodecyl)pyrrolo[3,4-c]pyrrole-1,4-(2H,5H)-dione-based donor-acceptor alternating copolymer bearing 5,5'-di(thiophen-2-yl)-2,2'-biselenophene exhibiting 1.5 cm2·V(-1)·s(-1) hole mobility in thin-film transistors.
TL;DR: A novel diketopyrrolopyrrole-based π-conjugated copolymers P(DPP-alt-DTBSe), 5, and a known copolymer P( DPP-Alt-QT), 4, have been synthesized in 80-90% yield using the Stille coupling reaction.
Journal ArticleDOI
Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial.
Byeong Keuk Kim,Sung Jin Hong,Yun-Hyeong Cho,Kyeong Ho Yun,Yong Hoon Kim,Yongsung Suh,Jae Young Cho,Ae-Young Her,Sungsoo Cho,Dong Woon Jeon,Sang-Yong Yoo,Deok Kyu Cho,Bum-Kee Hong,Hyuck Moon Kwon,Chul Min Ahn,Dong Ho Shin,Chung Mo Nam,Jung Sun Kim,Young Guk Ko,Donghoon Choi,Myeong Ki Hong,Yangsoo Jang,Tico Investigators +22 more
TL;DR: Among patients with acute coronary syndromes treated with drug-eluting stents, ticagrelor monotherapy after 3 months of dual antiplatelet therapy, compared with ticagerelor-based 12-month dual anti Platelet therapy resulted in a modest but statistically significant reduction in a composite outcome of major bleeding and cardiovascular events at 1 year.